Status:
NOT_YET_RECRUITING
IBIS Megastudy of Interventions to Encourage HIV Retesting
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
University of Pennsylvania
Kenya Medical Research Institute
Conditions:
HIV
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
In this study, the investigators will test the effectiveness of multiple low-cost behavioral interventions, designed with end-user input, to promote HIV retesting among adults in rural Kenya and Ugand...
Detailed Description
HIV re-testing is crucial in ensuring early identification of disease to promote well-being of an individual as well as preventing onward spread of infection. The IBIS megastudy of interventions to en...
Eligibility Criteria
Inclusion
- at least 15 years of age
- Accessing HIV testing services at study-associated hospitals or clinics
- At increased risk of HIV infection (defined by national (Kenya or Uganda) MoH criteria)
- Documented negative HIV antibody test at time of enrollment
- No intent to migrate out of community in next 3 months
- Daily access to a mobile phone (required since some of the interventions will be delivered by phone)
Exclusion
- HIV-positive at time of enrollment
Key Trial Info
Start Date :
December 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
40000 Patients enrolled
Trial Details
Trial ID
NCT06971367
Start Date
December 1 2025
End Date
December 1 2027
Last Update
October 23 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Kenya Medical Research Institution (KEMRI)
Mbita, Kenya
2
Infectious Diseases Research Collaboration (IDRC)
Mbarara, Uganda